Over 900 Oracle E-Business Suite (EBS) instances have been found exposed online amid ongoing attacks exploiting a critical ...

Oracle (ORCL) is down sharply in 2026, but analysts stay bullish on cloud growth, backlog and upside potential.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Threat actors have started exploiting CVE-2026-46817, a critical-severity vulnerability in Oracle E-Business Suite’s Payments ...

Oracle's stock fell 19% this week, the steepest drop since August 2001, the depths of the dot-com bust. The company's capital ...

Other takeaways from the filing, the company's guidance and a prospectus on its capital needs suggest that Oracle's capex ...

Oracle topped quarterly expectations, but free cash flow is negative, and the company plans to raise more capital for data center projects.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Oracle has decreased its workforce by tens of thousands in the past year while spending $70 billion to fund its AI expansion. Oracle is spending big on artificial intelligence—to the tune of $70 ...

One of the world’s leading artificial intelligence companies has implored the industry to pause development on AI, because the latest models could be reaching a tipping point where they become capable ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...